A Day Up For Nektar Therapeutics
Mon, Aug 07, 2023 at 07:02 PM
Nektar Therapeutics (NKTR:NASDAQ) shot up at $1.02, representing a gain of 91.5%. On Mon, Aug 07, 2023, NKTR:NASDAQ touched a New 2-Week High of $1.02. The stock appeared on our News Catalysts scanner on Mon, Aug 07, 2023 at 06:52 AM in the 'PATNERSHIP' category. From Mon, Jul 24, 2023, the stock recorded 40.00% Up Days and 45.45% Green Days
About Nektar Therapeutics (NKTR:NASDAQ)
Nektar Therapeutics Inc is a biopharmaceutical company engaged in the development of new molecules to treat diseases with unmet medical needs. The company's research and development activities involve small-molecule drugs, and peptides.
Top 10 Gainers:
- VistaGen Therapeutics, Inc. (VTGN:NASDAQ), 676.79%
- Save Foods Inc. (SVFD:NASDAQ), 143.75%
- Nektar Therapeutics (NKTR:NASDAQ), 91.51%
- ParaZero Technologies Ltd. (PRZO:NASDAQ), 40.27%
- Mallinckrodt plc (MNK:NYSEMKT), 32.12%
- Missfresh Limited (MF:NASDAQ), 31.82%
- Sequans Communications S.A. (SQNS:NYSE), 30.99%
- Tabula Rasa HealthCare, Inc. (TRHC:NASDAQ), 30.52%
- Peak Bio Inc Com (PKBO:NASDAQ), 28.48%
- Sovos Brands Inc. (SOVO:NASDAQ), 25.19%